To test this hypothesis, we used cancer cells that were either endogenously deficient in functional NAPRT (Namalwa) (Figure 3B) or that lacked the NAPRT gene by genetic knock-out (Jurkat NAPRT KO and ML2 NAPRT KO). The gene discussed is NAPRT; the disease is cancer.